Unlock stock picks and a broker-level newsfeed that powers Wall Street.
0.3040
-0.0050
(-1.62%)
At close: April 4 at 5:29:56 PM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-50,228
-50,228
-43,401
-41,165
-45,024
Investing Cash Flow
--
--
96
-260
--
Financing Cash Flow
45,151
45,151
33,608
23,060
76,371
End Cash Position
16,337
16,337
21,415
31,114
49,479
Issuance of Capital Stock
45,056
45,056
36,503
23,107
66,662
Issuance of Debt
--
--
--
--
20,000
Free Cash Flow
-50,228
-50,228
-43,401
-41,165
-45,024
12/31/2021 - 4/19/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ZH6.BE Biohaven Ltd. R
17.10
-8.56%
5KW.F SkinBioTherapeutics plc
0.2620
-6.43%
HQ1.MU Oruka Therapeutics Inc. R
8.25
-6.25%
2HA.MU Spero Therapeutics Inc
0.5750
-10.99%
DIABIO.ST Diagonal Bio AB (publ)
0.0145
0.00%
SIMRIS-B.ST Simris Group AB (PUBL)
0.1105
-1.34%
CHOSA.ST CHOSA Oncology AB
0.6680
-4.57%
HPHA.F Heidelberg Pharma AG
2.6500
-6.03%
2CUREX.ST 2cureX AB (publ)
0.3500
-6.17%
22Z.SG Zealand Pharma A/S
58.30
-6.65%